Woo Jin Lee, Sook Jung Yun, Joon Min Jung, Joo Yeon Ko, Kwang Ho Kim, Dong Hyun Kim, Myung Hwa Kim, You Chan Kim, Jung Eun Kim, Chan-Ho Na, Je-Ho Mun, Jong Bin Park, Ji-Hye Park, Hai-Jin Park, Dong Hoon Shin, Jeonghyun Shin, Sang Ho Oh, Seok-Kweon Yun, Dongyoun Lee, Seok-Jong Lee, Seung Ho Lee, Young Bok Lee, Soyun Cho, Sooyeon Choi, Jae Eun Choi, Mi Woo Lee
{"title":"Primary Cutaneous CD30+ Lymphoproliferative Disorders in South Korea: A Nationwide, Multi-Center, Retrospective, Clinical, and Prognostic Study.","authors":"Woo Jin Lee, Sook Jung Yun, Joon Min Jung, Joo Yeon Ko, Kwang Ho Kim, Dong Hyun Kim, Myung Hwa Kim, You Chan Kim, Jung Eun Kim, Chan-Ho Na, Je-Ho Mun, Jong Bin Park, Ji-Hye Park, Hai-Jin Park, Dong Hoon Shin, Jeonghyun Shin, Sang Ho Oh, Seok-Kweon Yun, Dongyoun Lee, Seok-Jong Lee, Seung Ho Lee, Young Bok Lee, Soyun Cho, Sooyeon Choi, Jae Eun Choi, Mi Woo Lee","doi":"10.5021/ad.24.120","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary cutaneous CD30+ lymphoproliferative disorders (pcCD30-LPDs) are a diseases with various clinical and prognostic characteristics.</p><p><strong>Objective: </strong>Increasing our knowledge of the clinical characteristics of pcCD30-LPDs and identifying potential prognostic variables in an Asian population.</p><p><strong>Methods: </strong>Clinicopathological features and survival data of pcCD30-LPD cases obtained from 22 hospitals in South Korea were examined.</p><p><strong>Results: </strong>A total of 413 cases of pcCD30-LPDs (lymphomatoid papulosis [LYP], n=237; primary cutaneous anaplastic large cell lymphoma [C-ALCL], n=176) were included. Ninety percent of LYP patients and roughly 50% of C-ALCL patients presented with multiple skin lesions. Both LYP and C-ALCL affected the lower limbs most frequently. Multiplicity and advanced T stage of LYP lesions were associated with a chronic course longer than 6 months. Clinical morphology with patch lesions and elevated serum lactate dehydrogenase were significantly associated with LPDs during follow-up in LYP patients. Extracutaneous involvement of C-ALCL occurred in 13.2% of patients. Lesions larger than 5 cm and increased serum lactate dehydrogenase were associated with a poor prognosis in C-ALCL. The survival of patients with C-ALCL was unaffected by the anatomical locations of skin lesions or other pathological factors.</p><p><strong>Conclusion: </strong>The multiplicity or size of skin lesions was associated with a chronic course of LYP and survival among patients with C-ALCL.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"37 2","pages":"75-85"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965872/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5021/ad.24.120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Primary cutaneous CD30+ lymphoproliferative disorders (pcCD30-LPDs) are a diseases with various clinical and prognostic characteristics.
Objective: Increasing our knowledge of the clinical characteristics of pcCD30-LPDs and identifying potential prognostic variables in an Asian population.
Methods: Clinicopathological features and survival data of pcCD30-LPD cases obtained from 22 hospitals in South Korea were examined.
Results: A total of 413 cases of pcCD30-LPDs (lymphomatoid papulosis [LYP], n=237; primary cutaneous anaplastic large cell lymphoma [C-ALCL], n=176) were included. Ninety percent of LYP patients and roughly 50% of C-ALCL patients presented with multiple skin lesions. Both LYP and C-ALCL affected the lower limbs most frequently. Multiplicity and advanced T stage of LYP lesions were associated with a chronic course longer than 6 months. Clinical morphology with patch lesions and elevated serum lactate dehydrogenase were significantly associated with LPDs during follow-up in LYP patients. Extracutaneous involvement of C-ALCL occurred in 13.2% of patients. Lesions larger than 5 cm and increased serum lactate dehydrogenase were associated with a poor prognosis in C-ALCL. The survival of patients with C-ALCL was unaffected by the anatomical locations of skin lesions or other pathological factors.
Conclusion: The multiplicity or size of skin lesions was associated with a chronic course of LYP and survival among patients with C-ALCL.